Uncategorized
This week in Drug Discovery (8 June – 12 June)
News round-up for 8 June – 12 June by Bruno Quinney, Content Team at DDW.
This week, new research suggests anti-IL-1β drugs could prevent lung cancer. Elsewhere, the UK is set to benefit from specialised blood tests and funding for researchers.
The top stories:
New research suggests anti-IL-1β drugs could prevent lung cancer
Researchers at the Francis Crick Institute and University College London (UCL) have identified a 14-protein signature in the blood that could identify who would benefit from cancer prevention drugs.
UK should offer US-style incentives in rare diseases, says biotech
The UK Medicines & Healthcare Regulatory Agency (MHRA) is consulting on a new regulatory framework for bringing rare disease drugs more quickly to market.
Read more…
GLP-1 reduces liver fat by 63%, trial results show
The glucagon/GLP-1 dual agonist survodutide could reduce liver fat by 63%, results show.
Read more…
UK cancer patients to benefit from genetic testing rollout
Hundreds of UK cancer patients will benefit from a rollout of specialised blood tests, providing improved access to genetic testing and personalised therapies.
Over £37m funding to boost early career researchers in the UK
The National Institute for Health and Care Research (NIHR) is awarding £37 ($49) million in funding to medical research charities to support early career researchers.
Read more…
The post This week in Drug Discovery (8 June – 12 June) appeared first on Drug Discovery World (DDW).